Pangea Bio

Transformative medicines inspired by nature's neuroactive chemistry

London, United Kingdom · Founded 2021

Headquarters
London
Employees
1–10
Founded
2021
Business Model
B2B

About

Pangea Bio is a UK-based clinical-stage biotechnology company developing transformative medicines for neurological and mental health disorders. The company uses AI to unlock nature's neuroactive chemistry, identifying and optimizing naturally occurring compounds to create novel small molecule therapeutics. Pangea's lead program focuses on next-generation TrkB receptor activators that drive neuronal and synaptic plasticity, targeting conditions including schizophrenia, depression, and Alzheimer's disease. In December 2025, Pangea received Clinical Trial Authorization from the UK MHRA for its lead candidate OT-003, marking its transition to a clinical-stage company.

Summary

Pangea Bio is a Biotech company based in London, United Kingdom, founded in 2021.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Pangea Bio on Indexed.vc
<a href="https://indexed.vc/companies/pangea-bio"><img src="https://indexed.vc/api/badge/company/pangea-bio" alt="Pangea Bio on Indexed.vc" width="260" height="76" /></a>